[Influence of the route of administration on the metabolism of a beta-adrenergic blocker, o-[3-(tert-butylamino)-2-hydroxypropoxy]-benzonitrile (bunitrolol) (author's transl)].
D000284:Administration, Oral; D000319:Adrenergic beta-Antagonists; D000818:Animals; D007275:Injections, Intravenous; D008297:Male; D011412:Propanolamines / Q000008:administration & dosage* / Q000378:metabolism; D051381:Rats
D000319:Adrenergic beta-Antagonists; D011412:Propanolamines